Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,347.40 -6.97 -0.05%
S&P 500 1,666.48 -0.99 -0.06%
Nasdaq 3,496.89 -2.07 -0.06%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Cell Therapeutics Inc

+ Add to Watchlist

CTIC:US

1.1900 USD 0.0300 2.59%

As of 14:39:12 ET on 05/20/2013.

Company Profile for Cell Therapeutics Inc (CTIC)

Cell Therapeutics, Inc. is a biopharmaceutical company. The Company researches and develops cancer drugs.

Contact Information

Cell Therapeutics Inc

501 Elliot Avenue West
Suite 400
Seattle, WA 98119
United States
Phone: 1-206-282-7100

Key Executives for Cell Therapeutics Inc (CTIC)

James A BiancoPresident/CEO/Co-FounderLouis A BiancoExec VP:Finance/Co-Founder
Jack W SingerExec VP:Global Medical AffairsSteven E BennerExec VP/Chief Medical Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil